A new planning guide funded by the Agency for Healthcare Research and Quality (AHRQ) is designed to help communities nationwide make sure that all Americans have needed drugs and vaccines in the event of a natural epidemic or bioterrorist attack.
Developed by a team of researchers in the Department of Public Health at Weill Medical College of Cornell University and New York-Presbyterian Hospital led by Nathaniel Hupert, MD, MPH, the guide complements the Strategic National Stockpile guidebook prepared by the Centers for Disease Control and Prevention (CDC), which includes a chapter on dispensing medications and vaccines.
States and localities are charged with the enormous task of readying medicines needed in an emergency, said Department of Health and Human Services Secretary Tommy G. Thompson. This guide goes a long way toward helping them put the necessary resources into place and to meeting the federal governments call for readiness.
The new guide, Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness, is designed to help state, county, and local officials meet federal requirements for a public health emergency.
The new guide:
* provides a framework for understanding the components of epidemic outbreak response (surveillance, stockpiling, distribution, dispensing, and follow-up care) and the planning and conduct of dispensing operations using specially designated dispensing clinics
* applies these concepts to develop model pill-dispensing and vaccination clinics run on the Bioterrorism and Epidemic Outbreak Model (BERM), a computer staffing model also developed by Hupert and his colleagues at Weill Cornell under contract to AHRQ that can be customized to meet local community needs
* discusses implementation of a command and control framework for dispensing clinics based on the CDCs National Incident Management System
Information is the most powerful resource we can provide communities in readying for such public health emergencies, said AHRQ director Carolyn M. Clancy, MD. We hope public health officials at all levels of government find this new planning guide to be helpful.
Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness can be found at http://www.ahrq.gov/research/cbmprophyl/cbmpro.htm. Printed copies are available by contacting AHRQs Publications Clearinghouse at 1-800-358-9295 or by sending an e-mail to ahrqpubs@ahrq.gov.
Source: Agency for Healthcare Research and Quality (AHRQ)
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.